Clinical safety and immunogenicity of two hiv vaccines sev-g (np) and ad35-grin in HIV-uninfected, healthy adult volunteers
Abstract
Development of vaccines that stimulate sustained humoral and/or cellular
immunity at mucosal HIV entry points is critical in the quest for an HIV vaccine. To achieve
this goal, we are investigating replication-competent viral vectors for mucosal delivery that ..............................
Citation
Karita, Etienne, et al. "Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G (NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers." AIDS research and human retroviruses 30.S1 (2014): A85-A85.Publisher
University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10385]